Study finds obese patients don't need to lose weight before total joint replacement

July 19, 2017

There's good news from UMass Medical School for overweight people with painfully arthritic hips and knees: A new study finds that obese patients who underwent knee or hip replacement surgery reported virtually the same pain relief and improved function as normal-weight joint replacement patients six months after surgery.

"Our data shows it's not necessary to ask patients to lose weight prior to surgery," said Wenjun Li, PhD, associate professor of medicine and lead author on the study. "It's challenging for a patient who is severely overweight and suffering in pain to exercise--often they just can't do it. Our evidence showed that severe morbidly obese patients can benefit almost equally as normal weight patients in pain relief and gains in physical function."

The aim of the study, published July 19 in the Journal of Bone and Joint Surgery, was to evaluate the extent of pain relief and functional improvement in total joint replacement patients with various levels of obesity. The researchers concluded that while obesity is associated with a greater risk of early complications, obesity in itself should not be a deterrent to undergoing total joint replacement to relieve symptoms.

Prior research has documented that obesity is associated with a small, but increased likelihood of infection after total knee replacement, which may discourage obese patients from having surgery. "However, in this paper we report that obese patients have comparable pain relief and functional outcomes after surgery," said Patricia Franklin, MD, MBA, MPH, professor of orthopedics & physical rehabilitation. "Patients should know that these benefits may outweigh risks."

Dr. Franklin is principal investigator of the Function and Outcomes Research for Comparative Effectiveness in Total Joint Replacement (FORCE-TJR) program from the federal Agency for Healthcare Research and Quality. She co-authored the paper with David Ayers, MD, the Arthur M. Pappas, MD, Chair in Orthopedics and chair and professor of orthopedics & physical rehabilitation; Jeroan J. Allison, MD, MS,, vice chair and professor of quantitative health sciences; and colleagues at Hartford Hospital and Geisinger Health Center.

Preoperative and 6-month postoperative data on function, joint pain and body mass index (BMI) from a national sample of 2,040 patients who had undergone total hip replacement and 2,964 who had undergone total knee replacement from May 2011 to March 2013 was collected. Preoperative and postoperative function and pain were evaluated according to BMI status, defined as under or of normal weight, overweight, obese, severely obese, or morbidly obese. A greater obesity level was associated with worse pain at baseline but greater postoperative pain relief, with average postoperative pain scores at six months similar across the BMI levels.

"This surprised us a little bit. Past analysis showed that obesity is associated with outcomes to some degree, but here we see the magnitude is so small it won't make much difference, and severely obese patients can benefit a lot from the surgery," said Dr. Li. "Patients who can lose weight should, but we acknowledge many people can't, or it will take a long time during which their joints will worsen. If they can get the surgery earlier, once function is restored they can better address obesity."

"Losing weight by making appropriate dietary changes and increasing the calories burned each day through water exercise programs and other aerobic, non-weight bearing activities is always appropriate to decrease the risk of complications for overweight patients," said FORCE-TJR co-investigator Dr. Ayers. "This manuscript adds to our collective knowledge regarding the risk benefit ratio of total joint replacement surgery in obese patients. The debate will continue in the morbidly obese patients with BMI over 40, and the super obese with a BMI over 50, regarding what steps can and should be taken to lower the risks before these elective surgical procedures."

Funded by a $12 million grant, the FORCE-TJR research program has developed a national database of surgical results and patient-reported outcomes from more than 30,000 patients. FORCE-TJR is unique in quantifying patient reported pain and function after surgery in order to assess multiple factors associated with the best results.

"Other registries primarily evaluate implant longevity," said Franklin. "Thus FORCE-TJR has taken the lead in evaluating patient factors and outcomes."
-end-


University of Massachusetts Medical School

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.